D e s i g n
Randomized (allocation concealed*), blinded (ultrasonographers, technicians who measured D-dimer levels, and outcome assessors),* controlled trial with 3-month follow-up.
S e t t i n g
Thrombosis units and emergency departments of 5 academic health centers in Canada.
P a t i e n t s
1096 outpatients (mean age 58 y, 58% women) who had suspected lower-extremity DVT. Exclusion criteria included refusal or inability to consent, geographic inaccessibility, symptom resolution for > 72 hours, suspected pulmonary embolism, life expectancy < 3 months, use of therapeutic anticoagulation for > 48 hours, pregnancy, and age < 18 years. 1082 patients (99%) completed follow-up and were included in the analysis.
I n t e r v e n t i o n
Patients were stratified by the application of a clinical model as "likely" or "unlikely" to have DVT and allocated to D-dimer testing (n = 566) or VUI alone (n = 530). Patients in the D-dimer group received VUI if they were "likely" to have DVT or if they were "unlikely" to have DVT but the D-dimer test result was positive. Patients who were "unlikely" to have DVT and whose D-dimer test result was negative did not receive VUI. Patients in the VUI-alone group who were "likely" to have DVT received VUI 1 week later if the first test result was negative.
M a i n o u t c o m e m e a s u r e
Development of proximal DVT or pulmonary embolism in patients in whom DVT had initially been ruled out.
M a i n r e s u l t s
The overall prevalence of DVT or pulmonary embolism was 15.7% during followup. The groups did not differ for rate of proximal DVT or pulmonary embolism in patients in whom DVT had initially been ruled out (Table) . The mean number of ultrasonographic tests per patient was lower in the D-dimer group than in the VUI-alone group (0.78 vs 1.34, P = 0.008).
C o n c l u s i o n
In outpatients with suspected deep venous thrombosis (DVT), the use of D-dimer testing reduced the need for venous ultrasonographic imaging and ruled out DVT in patients judged clinically unlikely to have DVT without compromising safety. 
Sources of funding: Heart and Stroke Foundation of Ontario and Heart and Stroke Foundation of

C o m m e n t a r y
Previous cohort studies have shown the usefulness of D-dimer testing along with an assessment of the clinical probability of disease to exclude a diagnosis of DVT (1, 2) . In this study, however, Wells and colleagues report the first randomized trial testing a diagnostic strategy incorporating D-dimer testing and convincingly show the value of this approach. Whereas the study was powered to show that the rate of DVT during follow-up would be < 0.8% higher in the D-dimer group than in the VUI group, the rate was actually 0.9% lower in the D-dimer group than in the VUI group, thus showing that the 2 approaches are equivalent in safety. Furthermore, fewer extremity ultrasonographic tests were done in the D-dimer group than in the VUI group. This implies that use of D-dimer testing may be cost-saving, although this observation needs formal testing.
The authors used either of 2 assays: SimpliRED, a qualitative red-cell agglutination assay, or IL-Test, an automated quantitative assay. In previous work, Kovacs and colleagues reported negative predictive values of 96% for SimpliRED and 97% for IL-Test (3). Such high negative predictive values will not be seen in situations where the prevalence of thrombosis is higher.
